InvestorsHub Logo
Followers 2
Posts 199
Boards Moderated 0
Alias Born 09/16/2017

Re: None

Monday, 05/11/2020 4:25:36 PM

Monday, May 11, 2020 4:25:36 PM

Post# of 15618
Tilray, Inc. Reports First Quarter 2020 Financial Results

Quarterly Revenue Increased 126% to $52.1 Million (C$70.7 Million) Compared to the First Quarter of 2019 and 11% Sequentially from the Fourth Quarter of 2019

International Medical Cannabis Sales Exceeded Canada Medical Sales by 43% in the Quarter

Implemented Cost Reductions Designed to Achieve Approximately $40 Million Annualized Savings

Reduced Net Loss by $35 Million, or 16%, Compared to the Fourth Quarter of 2019

Implemented COVID-19 Related Protocols to Ensure the Health of Our Global Workforce and Satisfy Patient and Consumer Needs

Focused on Achieving Positive Adjusted EBITDA by End of the Fourth Quarter of 2020

This looks very interesting especially since Marijuana is a known treatment for Covid 19 prevention.....Tomorrow should be a great day for you holders of Tilray.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TLRY News